Consistently, immunofluorescence staining revealed that while s63845 treatment increased caspase-3 activation in both STEAP4-expressing xenograft tissue and control tumor tissue, STEAP4 expression was able to reduce the frequencies of cleaved caspase-3-positive cells in s63845-treated tumor (Supplementary Fig. 4d). This evidence concerns the gene CASP3 and neoplasm.